Informações:
Falhas:
ID
17546
Descrição
Latino Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) and COPEGUS (Ribavirin) in Treatment-Naive Patients With Chronic Hepatitis C-Genotype 1.; ODM derived from: https://clinicaltrials.gov/show/NCT00107653
Link
https://clinicaltrials.gov/show/NCT00107653
Palavras-chave
Versões (1)
- 22/09/2016 22/09/2016 -
Transferido a
22 de setembro de 2016
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Hepatitis C, Chronic NCT00107653
Eligibility Hepatitis C, Chronic NCT00107653
- StudyEvent: Eligibility
Similar models
Eligibility Hepatitis C, Chronic NCT00107653
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Adult | Age
Item
adult patients 18-65 years of age
boolean
C0001675 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C0001779 (UMLS CUI [2])
Chronic hepatitis C genotype 1
Item
chc, genotype 1
boolean
C4049392 (UMLS CUI [1])
Chronic Hepatitis C Evidence Serologic | Antibody test
Item
serologic evidence of chc infection by an antibody test
boolean
C0524910 (UMLS CUI [1,1])
C3887511 (UMLS CUI [1,2])
C0205473 (UMLS CUI [1,3])
C0580327 (UMLS CUI [2])
C3887511 (UMLS CUI [1,2])
C0205473 (UMLS CUI [1,3])
C0580327 (UMLS CUI [2])
Chronic liver disease Consistent with Hepatitis C, Chronic | Biopsy of liver
Item
chronic liver disease, consistent with chc infection on a liver biopsy obtained within the past 18 months
boolean
C0341439 (UMLS CUI [1,1])
C0332290 (UMLS CUI [1,2])
C0524910 (UMLS CUI [1,3])
C0193388 (UMLS CUI [2])
C0332290 (UMLS CUI [1,2])
C0524910 (UMLS CUI [1,3])
C0193388 (UMLS CUI [2])
Compensated liver disease
Item
compensated liver disease
boolean
C3839044 (UMLS CUI [1])
Contraceptive methods Quantity | Gender
Item
use of 2 forms of contraception during the study in both men and women
boolean
C0700589 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0079399 (UMLS CUI [2])
C1265611 (UMLS CUI [1,2])
C0079399 (UMLS CUI [2])
interferon | Ribavirin
Item
previous interferon or ribavirin therapy
boolean
C0733470 (UMLS CUI [1])
C0035525 (UMLS CUI [2])
C0035525 (UMLS CUI [2])
Antiviral Therapy Systemic
Item
systemic antiviral therapy less than 24 weeks before first dose of study drug or expected need for this treatment any time during the study
boolean
C0280274 (UMLS CUI [1,1])
C0205373 (UMLS CUI [1,2])
C0205373 (UMLS CUI [1,2])
medical condition Associated with Chronic liver disease | Hemochromatosis | Hepatitis, Autoimmune | Alcoholic Liver Diseases | Exposure to toxin
Item
medical condition associated with chronic liver disease (eg, hemochromatosis, autoimmune hepatitis, alcoholic liver disease, toxin exposure)
boolean
C3843040 (UMLS CUI [1,1])
C0332281 (UMLS CUI [1,2])
C0341439 (UMLS CUI [1,3])
C0018995 (UMLS CUI [2])
C0241910 (UMLS CUI [3])
C0023896 (UMLS CUI [4])
C0040537 (UMLS CUI [5])
C0332281 (UMLS CUI [1,2])
C0341439 (UMLS CUI [1,3])
C0018995 (UMLS CUI [2])
C0241910 (UMLS CUI [3])
C0023896 (UMLS CUI [4])
C0040537 (UMLS CUI [5])
Decompensated liver disease
Item
decompensated liver disease
boolean
C4075847 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
women who are pregnant or breastfeeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])